Tokyo, Japan

Takashi Futami

USPTO Granted Patents = 41 


 

Average Co-Inventor Count = 1.7

ph-index = 11

Forward Citations = 371(Granted Patents)


Location History:

  • Kawasaki, JP (1998)
  • Tokyo, JP (1987 - 2016)

Company Filing History:


Years Active: 1987-2016

Loading Chart...
Loading Chart...
Loading Chart...
41 patents (USPTO):Explore Patents

Title: Takashi Futami: Innovator in Cancer Therapeutics

Introduction

Takashi Futami, an esteemed inventor based in Tokyo, Japan, has made significant contributions to the field of oncology through his innovative research and development of therapeutics. With an impressive portfolio of 41 patents, his work focuses on creating compounds that can effectively combat different types of cancer.

Latest Patents

Futami's recent patents include a novel nitrogen-containing aromatic heterocyclic compound, which has emerged as a promising prophylactic and therapeutic agent specifically for bladder cancer. This compound exhibits inhibitory action on various fibroblast growth factor receptors (FGFR), particularly mutant FGFR3, making it relevant for treating not only bladder cancer but also other cancers associated with FGFR1, FGFR2, and FGFR3. Additionally, he has developed a method for detecting a novel FGFR4 mutant, aimed at identifying genetic mutations linked to cancer. This method facilitates the diagnosis of cancer by detecting specific mutations in the FGFR4 tyrosine kinase domain, allowing for targeted therapies.

Career Highlights

Throughout his career, Takashi Futami has been affiliated with notable organizations such as Stanley Electric Co., Ltd and Astellas Pharma GmbH. His work in these companies has significantly advanced cancer research and therapeutic methods, contributing to improved patient outcomes.

Collaborations

Futami has collaborated with distinguished colleagues, including Teruo Koike and Takuya Kushimoto. These partnerships have fostered innovation and broadened the scope of his research, leading to advancements in cancer treatment methodologies.

Conclusion

Takashi Futami's dedication to the field of cancer therapeutics is evidenced by his extensive patent portfolio and impactful research contributions. His innovative compounds and detection methods hold the potential to revolutionize cancer treatment and provide hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…